Recombinant Human NACHRA5 (C-6His)

Description

EnkiLife provides the Recombinant Human NACHRA5 (C-6His) protein,aslo know as Neuronal Acetylcholine Receptor Subunit Alpha-5,CHRNA5,NACHRA5, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Neuronal Acetylcholine Receptor Subunit α-5/NACHRA5 is produced by our Mammalian expression system and the target gene encoding Arg23-Thr254 is expressed with a 6His tag at the C-terminus.Accession:P30532. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:27.6 KDa. Background:Neuronal Acetylcholine Receptor Subunit α-5 (NACHRA5) is a member of the ligand-gated ion channel family. Neuronal AChR is composed of two different type of subunits: α and non-α. When NACHRA5 binds to acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits, leading to the opening of an ion-conducting channel across the plasma membrane. Genetic variations in NACHRA5 have been related to susceptibility to smoking-related behavioral traits and lung cancer, contributing to the smoking quantitative trait locus 3.